July 1st at noon
Summary: The number of novel substances used/misused in the United States has expanded significantly in the past decade. Substance use/misuse has gone global and has spread rapidly via Internet markets. Healthcare providers will encounter patients inebriated by a variety of these novel psychoactive substances. This ECHO is factual case-based, highlighting the variety of inebriated patients that may be encountered and the associated signs and symptoms. This ECHO will discuss emerging substances, such as synthetic cannabinoids, synthetic cathinones, kratom, phenibut, and designer opioids and benzodiazepines. This talk will also explain the limitations of routine urine drug screens.
The goal of this ECHO session for providers and community members to develop a better understanding of emerging trends in these novel substances of misuse.
1) Discuss the most recent epidemiological trends in substance use/misuse, especially focusing on novel psychoactive substances
2) Review the clinical effects of the various classes of substances emerging
3) Highlight the appropriate management of the intoxicated patient
4) Review the limitations of currently available “urine drug screens”.
|1 - Novel Substances of Misuse||7/1/2022|